Armata Pharmaceuticals (ARMP) News Today → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free ARMP Stock Alerts $2.53 +0.03 (+1.20%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArmata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Short Interest Updateamericanbankingnews.com - April 16 at 5:58 AMArmata Pharmaceuticals (NYSEAMERICAN:ARMP) Trading Down 1.8%marketbeat.com - April 13 at 12:40 AMBuy Rating Affirmed for Armata Pharmaceuticals Amid Progress in Bacteriophage Therapy Developmentmarkets.businessinsider.com - March 25 at 9:35 PMArmata Pharmaceuticals Inc (ARMP) Earnings: Navigates Through R&D to Narrow Lossesfinance.yahoo.com - March 23 at 6:02 AMBuy Rating Affirmed for Armata Pharmaceuticals Amid Clinical Progress and Strategic Growthmarkets.businessinsider.com - March 22 at 6:26 PMArmata Pharmaceuticals (NYSEAMERICAN:ARMP) Rating Reiterated by HC Wainwrightmarketbeat.com - March 22 at 11:45 AMArmata Pharmaceuticals, Inc.: Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Updatefinanznachrichten.de - March 22 at 8:33 AMArmata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Updatefinance.yahoo.com - March 21 at 5:31 PMINVA Apr 2024 15.000 callfinance.yahoo.com - March 15 at 9:13 PMArmata Pharmaceuticals (ARMP) to Release Earnings on Thursdaymarketbeat.com - March 13 at 7:39 AMINVA Mar 2024 7.500 callfinance.yahoo.com - March 10 at 5:07 PMArmata secures $35 million to fund phage therapy trialsinvesting.com - March 6 at 4:20 PMArmata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Sees Large Decrease in Short Interestmarketbeat.com - March 5 at 7:49 AMArmata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innovivafinance.yahoo.com - March 4 at 4:17 PMArmata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summitfinance.yahoo.com - February 21 at 8:42 AMArmata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summitprnewswire.com - February 21 at 7:00 AMShort Interest in Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Drops By 17.9%marketbeat.com - February 14 at 2:45 AMArmata Pharmaceuticals Inc (ARMP)investing.com - February 10 at 5:30 PMArmata Pharmaceuticals Inc ARMPmorningstar.com - February 2 at 10:01 PMShort Interest in Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Rises By 9.4%marketbeat.com - January 3 at 3:38 PMRobust Advancements and Strategic Planning: Key Drivers for Armata Pharmaceuticals’ Buy Ratingmarkets.businessinsider.com - November 15 at 11:46 PMArmata Pharmaceuticals Inc (ARMP) Reports Q3 2023 Financial Results and Corporate Updatesfinance.yahoo.com - November 15 at 1:46 PMArmata Pharmaceuticals, Inc.: Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Updatefinanznachrichten.de - November 15 at 8:45 AMArmata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Updatefinance.yahoo.com - November 14 at 7:41 PMLexeo Therapeutics Inc.money.usnews.com - November 6 at 10:49 PMArmata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conferencefinance.yahoo.com - October 30 at 9:28 AMArmata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023finance.yahoo.com - October 19 at 8:55 AMArmata Pharmaceuticals (ARMP) Price Target Increased by 14.29% to 8.16msn.com - October 4 at 10:01 PMArmata Pharmaceuticals: Promising Clinical Trials and New Leadership Bolster Buy Recommendationmarkets.businessinsider.com - September 28 at 7:47 AMArmata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureusfinance.yahoo.com - September 26 at 8:18 AMArmata Pharmaceuticals to Participate in the Cantor Global Healthcare Conferencefinance.yahoo.com - September 21 at 7:37 AMArmata Pharma (ARMP) Stock Surges 130% in a Month: Here's Whyuk.news.yahoo.com - August 22 at 4:04 PMArmata Pharmaceuticals, Inc. (ARMP) Now Trades Above Golden Cross: Time to Buy?finance.yahoo.com - August 17 at 5:23 PMLadenburg Thalmann & Co. Reaffirms Their Buy Rating on Armata Pharmaceuticals (ARMP)markets.businessinsider.com - August 15 at 10:21 AMArmata Pharmaceuticals, Inc.: Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Updatefinanznachrichten.de - August 14 at 10:04 AMArmata Pharmaceuticals GAAP EPS of -$0.17, revenue of $0.98Mseekingalpha.com - August 14 at 10:04 AMArmata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Updatefinance.yahoo.com - August 14 at 10:04 AMARMP - Armata Pharmaceuticals, Inc.finance.yahoo.com - August 14 at 5:17 AMDow Surges 150 Points; Domino's Pizza Earnings Top Expectationsbenzinga.com - July 24 at 7:36 PMArmata Pharmaceuticals gets $25M in financing and new executive chiefmsn.com - July 11 at 10:00 AMArmata Pharmaceuticals Announces Oral Presentation Detailing Results from the Phase 1b/2a SWARM-P.a. Clinical Trial at the 6th World Conference on Targeting Phage Therapyfinance.yahoo.com - May 31 at 9:41 AMHC Wainwright & Co. Reiterates Armata Pharmaceuticals (ARMP) Buy Recommendationmsn.com - May 12 at 9:53 AMArmata Pharmaceuticals, Inc.: Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Updatefinanznachrichten.de - May 12 at 7:49 AMArmata Pharmaceuticals GAAP EPS of -$0.40, revenue of $0.79Mseekingalpha.com - May 11 at 8:26 PMArmata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimatesfinance.yahoo.com - May 11 at 8:26 PMArmata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Updatefinance.yahoo.com - May 11 at 4:16 PMArmata Pharmaceuticals, Inc. (ARMP)uk.finance.yahoo.com - April 6 at 12:11 AMArmata Pharmaceuticals, Inc.: Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Updatefinanznachrichten.de - March 17 at 7:08 AMArmata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Updatefinance.yahoo.com - March 16 at 8:35 PMArmata Pharma Shares Up 24% After Positive Cystic Fibrosis Therapeutic Trial Datamarketwatch.com - March 6 at 6:04 PM Get Armata Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARMP and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy ARMP Media Mentions By Week ARMP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARMP News Sentiment▼1.000.34▲Average Medical News Sentiment ARMP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARMP Articles This Week▼10▲ARMP Articles Average Week Get Armata Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARMP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cardiol Therapeutics News Today Outlook Therapeutics News Today Vigil Neuroscience News Today aTyr Pharma News Today bluebird bio News Today BioAtla News Today Xtant Medical News Today Zura Bio News Today Agenus News Today Omega Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:ARMP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
